7 terminated. 7 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 7 |
| Phase 1 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Death: new trials by email Literature Review of Death trials Research Report on Death
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II SB-913 - Mucopolysaccharidosis II, MPS II | Phase 1 / Phase 2 | Terminated | Sangamo Therapeutics | 9 | 2017-05-11 | 2022-10-25 |
| Cooling to Optimize Organ Life in Donor Study Cold isotonic fluid and central venous hypothermia catheter - Organ Transplantation From Brain-dead Donors | Phase 2 | Terminated | University of Pittsburgh | 4 | 2012-03-01 | 2018-02-07 |
| Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis 99mTc-NC100692 - Hypertrophic Cardiomyopathy, Acute Coronary Syndrome | Phase 2 | Terminated | Ottawa Heart Institute Research Corporation | 120 | 2011-05-01 | 2017-04-24 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome | Phase 1 / Phase 2 | Terminated | Talaris Therapeutics Inc. | 3 | 2011-04-01 | 2023-04-12 |
| Clinical Trial of Growth Hormone in MPS I, II, and VI Somatropin (DNA origin) - Mucopolysaccharidosis I, Mucopolysaccharidosis II | Phase 2 / Phase 3 | Terminated | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2 | 2008-11-01 | 2018-09-05 |
| Fetal Tracheal Balloon Study in Diaphragmatic Hernia Fetal tracheal obstruction with detachable balloon (device) - Diaphragmatic Hernia, Lung Disease | Phase 2 | Terminated | Rhode Island Hospital | 3 | 2008-09-01 | 2017-05-30 |
| Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial Epinephrine, Metoprolol - Cardiac Arrest, Sudden Cardiac Death | Phase 2 | Terminated | David Haines, MD | 7 | 2007-01-01 | 2017-05-25 |
Mucopolysaccharidosis II (3) · Sudden Infant Death (3) · Mucopolysaccharidosis I (2) · Acute Coronary Syndrome (1) · Adrenoleukodystrophy (1) · Brain Death (1) · Cardiomyopathy, Hypertrophic (1) · Death, Sudden (1) · Death, Sudden, Cardiac (1) · Dwarfism (1) · Heart Arrest (1) · Hernia, Diaphragmatic (1) · Leukodystrophy, Globoid Cell (1) · Leukodystrophy, Metachromatic (1) · Lung Diseases (1)
Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Death, Sudden (4) · Nervous System Diseases (4) · Neurobehavioral Manifestations (4) · Neurologic Manifestations (4) · Carbohydrate Metabolism, Inborn Errors (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Connective Tissue Diseases (3) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Heredodegenerative Disorders, Nervous System (3) · Infant Death (3) · Intellectual Disability (3)
Epinephrine (1) · Growth Hormone (1) · Human Growth Hormone (1) · Metoprolol (1) · Stem Cell Transplantation (1) · technetium 99m NC 100692 (1)
David Haines, MD (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Ottawa Heart Institute Research Corporation (1) · Rhode Island Hospital (1) · Sangamo Therapeutics (1) · Talaris Therapeutics Inc. (1) · University of Pittsburgh (1)
United States (6) · Canada (1)
David E Haines, MD (1) · Francois I Luks, MD, PhD (1) · Lynda E Polgreen, M.D. (1) · Suzanne T Ildstad, MD (1) · Terrence Ruddy, MD (1)